After Bombay HC rap, FDA withdraws orders against Cipla, MCA eateries
The Bombay High Court took a firm stance against the Maharashtra FDA, rebuking its treatment of Cipla and five eateries. The court underscored that the FDA's decisions compromised natural justice and displayed an inflexible approach. With the court's direction, the FDA rescinded its suspension of the Mumbai Cricket Association restaurants and reinstated Cipla's drug sale licence. The court called…
The Maharashtra Food and Drug Administration (FDA) has withdrawn two enforcement orders following a stern rebuke from the Bombay High Court. The court criticized the regulator for its handling of cases involving five MCA eateries in Bandra-Kurla Complex and a Cipla facility in Pune. The court warned the FDA of contempt action against officials involved in the MCA matter.
Following the court's warning, the FDA agreed to withdraw the suspension order for the eateries, which were 88% compliant with food safety rules after a fresh inspection. The court also criticized the FDA's decision to cancel the drug sale licences of Cipla's Pune facility, questioning the regulator's improper procedure and high-handed manner. The FDA withdrew the cancellation order after the court criticized its decision.
Written by urgent.news from Times of India's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- FDA withdraws Cipla licence order after HC rap economictimes.indiatimes.com
